Subgroup analysis of US and non-US patients in a global study of high-dose donepezil (23 mg) in moderate and severe Alzheimer's disease. (Q53332226)
Jump to navigation
Jump to search
scientific article published in September 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Subgroup analysis of US and non-US patients in a global study of high-dose donepezil (23 mg) in moderate and severe Alzheimer's disease. |
scientific article published in September 2012 |
Statements
Subgroup analysis of US and non-US patients in a global study of high-dose donepezil (23 mg) in moderate and severe Alzheimer's disease. (English)
Jeffrey L Cummings
1 reference
Stephen Salloway
Jacobo Mintzer
David Geldmacher
Yijun Sun
Jane Yardley
Joan Mackell
1 September 2012
27
6
421-432
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference